Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-149-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-04-20 till 2009-05-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline-conform study under GLP without deviations
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Commission Directive 2000/32/EC, Annex 4C, dated May 19, 2000
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Details on test material:
- - public name of test material:
Reaction mass of 6,13-dichloro-3,10-bis{[2-({[(2-chloroethyl)sulfonyl]alkanoyl}amino)ethyl]-amino}- polycarboheterocyclo 4,11-disulfonic acid, mono and/or disodium salt and 6,13-dichloro-3-{[2-({[(2-chloroethyl)sulfonyl]alkanoyl}amino) ethyl]amino}-10-[(2-{[4-(ethenylsulfonyl)alkanoyl]amino}ethyl)amino] polycarboheterocyclo -4,11-disulfonic acid, mono and/or di sodium salt
- Physical state: solid, dark blue powder
- Analytical purity: approx. 86.6%
- Lot/batch No.: VER 2108 BOP 02/07
- Expiration date of the lot/batch: November 30, 2012
- Storage condition of test material: At room temperature at about 20 °C
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Harlan Laboratories GmbH 33178 Borchen, Germany
- Age at study initiation: 8-12 weeks
- Weight at study initiation: males mean value 38.9 g (SD ± 2.8 g), females mean value 33.7 g (SD ± 3.5 g)
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: single, cage: Makrolon Type I, with wire mesh top Bedding: granulated soft wood bedding
- Diet (e.g. ad libitum): single pelleted standard diet, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum,
- Acclimation period: min 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 °C
- Humidity (%): 45 - 65%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light):artificial light 6.00 a.m. - 6.00 p.m.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: sterile water
- Justification for choice of solvent/vehicle: high solubility of the test item in water (60g/L
- Concentration of test material in vehicle: 50, 100 and 200mg/mL
- Amount of vehicle (if gavage or dermal): 10mL/kg bw
- Type and concentration of dispersant aid (if powder): not applicable - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: test item dissolved in vehicle (sterile water) at the respective concentration
- negative control: vehicle
- postive control : CPA; Cyclophosphamide, Supplier: Sigma-Aldrich Vertriebs GmbH, 82041 Deisenhofen, Germany
Dissolved in: deionised water, Dosing: 40 mg/kg b.w., Route and frequency of administration: orally, once, Volume administered: 10 mL/kg b.w., Solution prepared on day of administration. - Duration of treatment / exposure:
- single oral dose
- Frequency of treatment:
- single oral dose
- Post exposure period:
- animals sacrified 24 or 48h post dosing
Doses / concentrations
- Remarks:
- Doses / Concentrations:
50, 100, 200 and 1000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 6 males and 6 females
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide;
- Justification for choice of positive control(s):no data
- Route of administration: single oral dose
- Doses / concentrations: 40 mg/kg b.w., Volume administered: 10 mL/kg b.w.
Examinations
- Tissues and cell types examined:
- The animals were treated orally with the test item and examined for acute toxic symptoms at intervals of approximately 1 h, 2-4 h, 6 h, 24 h, 30 h, and 48 h after administration of the test item.
the animals(including controls) were weighed at the day of dosing, just prior to dosing - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
based on dose range finding study (2 animals per sex) with 100, 1000 and 2000mg/kg bw (see table 1)
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): see specific fields
DETAILS OF SLIDE PREPARATION:
-The animals were sacrificed using CO2 followed by bleeding
- The femora were removed, the epiphyses were cut off and the marrow was flushed out with foetal calf serum using a syringe.
- The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded.
- A small drop of the re-suspended cell pellet was spread on a slide.
- The smear was air-dried and then stained with May-Grünwald (Merck, 64293 Darmstadt, Germany)/Giemsa (Gurr, BDH Limited Poole, Great Britain)
- Cover slips were mounted with EUKITT (Kindler, 79110)
METHOD OF ANALYSIS:
- The analysis was performed with coded slides
- Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives.
- Per animal 2000 polychromatic erythrocytes (PCE) were analysed for micronuclei.
- To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes.
OTHER: - Evaluation criteria:
- MUTAGENIC:
- if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erythrocytes in a single dose group.
NON-MUTAGENIC in this system.
- A test item that fails to produce a biological relevant increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system. - Statistics:
- Statistical methods (nonparametric Mann-Whitney test (8)) will be used as an aid in evaluating the results. However, the primary point of consideration is the biological relevance of the results.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- ruffled fur, reduction of spontaneous activity, see table 1
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 500 to 2000 mg/kg bw
- Solubility: very soluable, 60g/L
- Clinical signs of toxicity in test animals: ruffled fur and reduction of spontaneous activity (see table 1)
- Evidence of cytotoxicity in tissue analyzed: not analyzed
- Rationale for exposure: 2000mg/kg bw is the highest allowed dose for animal testing in the EU
RESULTS OF DEFINITIVE STUDY
The mean number of polychromatic erythrocytes was not decreased after treatment with the test item as compared to the mean value of PCEs of the vehicle control indicating that test material did not have any cytotoxic properties in the bone marrow. (see table 2 for details)
In comparison to the corresponding vehicle controls there was no statistically significant or biologically relevant enhancement in the frequency of the detected micronuclei at any preparation interval and dose level after administration of the test item. The mean values of micronuclei observed after treatment with test material were near to the value of the vehicle control group.
Any other information on results incl. tables
Table 2 Summary of Micronucleus Test Results
test group |
dose mg/kg b.w. |
sampling time (h) |
PCEs with micronuclei (%) |
range |
PCE per 2000 erythocytes |
vehicle |
0 |
24 |
0.088 |
0 -4 |
1206 |
test item |
500 |
24 |
0.096 |
1 -4 |
1154 |
test item |
1000 |
24 |
0.138 |
1 -6 |
1234 |
test item |
2000 |
24 |
0.104 |
0 -5 |
1180 |
positive control |
40 |
24 |
2.142 |
16 -61 |
1124 |
test item |
2000 |
48 |
0.121 |
1 -5 |
1207 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse.
Therefore, test material is considered to be non-mutagenic in this micronucleus assay. - Executive summary:
This study was performed to investigate the potential of test material to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse.
The test item was formulated in sterile water, which was also used as vehicle control. The volume administered orally was 10 mL/kg b.w.. 24 h and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis.
Twelve animals (6 males, 6 females) per test group were evaluated for the occurrence of micronuclei. Per animal 2000 polychromatic erythrocytes (PCEs) were scored for micronuclei.
To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes.
The following dose levels of the test item were investigated:
24 h preparation interval: 500, 1000, and 2000 mg/kg b.w..
48 h preparation interval: 2000 mg/kg b.w..
The highest dose (2000 mg/kg; maximum guideline-recommended dose) was estimated by pre-experiments to be suitable.
After treatment with the test item the number of PCEs was not substantially decreased as compared to the mean value of PCEs of the vehicle control thus indicating that test material did not exert any cytotoxic effects in the bone marrow.
In comparison to the corresponding vehicle controls there was no biologically relevant or statistically significant enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test item and with any dose level used.
40 mg/kg b.w. cyclophosphamide administered orally was used as positive control which showed a substantial increase of induced micronucleus frequency.
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse.
Therefore, test material is considered to be non-mutagenic in this micronucleus assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Embora a ECHA disponibilize muito material em linha na sua língua, uma parte desta página está disponível apenas em inglês. Mais informações sobreas práticas de multilinguismo da ECHA.
Bem-vindo ao sítio Web da ECHA O navegador Internet Explorer 7 (e versões anteriores) não é totalmente suportado por este sítio Web. Por favor atualize o seu Internet Explorer para uma versão mais recente.
Este sítio Web utiliza cookies a fim de garantir a melhor experiência possível nos nossos sítios Web.
Saiba mais sobre como utilizar cookies.